223 related articles for article (PubMed ID: 12193112)
1. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.
Usmani BA; Harden B; Maitland NJ; Turner AJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():314S-317S. PubMed ID: 12193112
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of endothelin-converting enzyme-1 in human prostate cancer.
Dawson LA; Maitland NJ; Berry P; Turner AJ; Usmani BA
Exp Biol Med (Maywood); 2006 Jun; 231(6):1106-10. PubMed ID: 16741058
[TBL] [Abstract][Full Text] [Related]
3. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression.
Dawson LA; Maitland NJ; Turner AJ; Usmani BA
Br J Cancer; 2004 Apr; 90(8):1577-82. PubMed ID: 15083188
[TBL] [Abstract][Full Text] [Related]
4. Distribution of endothelin-converting enzyme-1 and neutral endopeptidase in human endometrium.
Iwase A; Ando H; Nagasaka T; Goto M; Harata T; Kikkawa F
J Histochem Cytochem; 2007 Dec; 55(12):1229-35. PubMed ID: 17712175
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neointima formation in an organ culture of human saphenous vein: a comparison of dual endothelin-converting enzyme/neutral endopeptidase and selective neutral endopeptidase inhibition.
Porter KE; Dickinson T; London NJ
J Vasc Surg; 2001 Sep; 34(3):548-54. PubMed ID: 11533610
[TBL] [Abstract][Full Text] [Related]
6. ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms.
Whyteside AR; Hinsley EE; Lambert LA; McDermott PJ; Turner AJ
Can J Physiol Pharmacol; 2010 Aug; 88(8):850-4. PubMed ID: 20725143
[TBL] [Abstract][Full Text] [Related]
7. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
Grantham JA; Schirger JA; Wennberg PW; Sandberg S; Heublein DM; Subkowski T; Burnett JC
Circulation; 2000 Apr; 101(16):1976-81. PubMed ID: 10779465
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
Hoang MV; Sansom CE; Turner AJ
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of enzymes regulating the activity of endothelin-1 in the lower segment of the human amnion during labor.
Kotani T; Iwase A; Tsuda H; Mano Y; Yamamoto E; Nakano T; Hasegawa Y; Li H; Sumigama S; Itakura A; Kikkawa F
Biol Reprod; 2013 Sep; 89(3):52. PubMed ID: 23863409
[TBL] [Abstract][Full Text] [Related]
10. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.
Smollich M; Götte M; Yip GW; Yong ES; Kersting C; Fischgräbe J; Radke I; Kiesel L; Wülfing P
Breast Cancer Res Treat; 2007 Dec; 106(3):361-9. PubMed ID: 17295044
[TBL] [Abstract][Full Text] [Related]
11. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
12. Neutral endopeptidase regulates neurogenic inflammatory responses induced by stimulation of human oral keratinocytes with bacterial lipopolysaccharide and nicotine.
Nakata M; Awano S; Kinoshita N; Yoshida A; Ansai T
Eur J Oral Sci; 2013 Oct; 121(5):434-42. PubMed ID: 24028591
[TBL] [Abstract][Full Text] [Related]
13. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX.
Turner AJ; Tanzawa K
FASEB J; 1997 Apr; 11(5):355-64. PubMed ID: 9141502
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.
Cailler F; Zappulla JP; Boileau G; Crine P
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):119-26. PubMed ID: 10377252
[TBL] [Abstract][Full Text] [Related]
15. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
Raoch V; Martinez-Miguel P; Arribas-Gomez I; Rodriguez-Puyol M; Rodriguez-Puyol D; Lopez-Ongil S
Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
[TBL] [Abstract][Full Text] [Related]
16. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
Johnson GD; Swenson HR; Ramage R; Ahn K
Arch Biochem Biophys; 2002 Feb; 398(2):240-8. PubMed ID: 11831855
[TBL] [Abstract][Full Text] [Related]
17. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
[TBL] [Abstract][Full Text] [Related]
18. Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion.
Lambert LA; Whyteside AR; Turner AJ; Usmani BA
Br J Cancer; 2008 Oct; 99(7):1114-20. PubMed ID: 18781169
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
Wallace EM; Moliterni JA; Moskal MA; Neubert AD; Marcopulos N; Stamford LB; Trapani AJ; Savage P; Chou M; Jeng AY
J Med Chem; 1998 Apr; 41(9):1513-23. PubMed ID: 9554884
[TBL] [Abstract][Full Text] [Related]
20. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
